Cargando…

Dysregulated hepatic lipid metabolism and gut microbiota associated with early-stage NAFLD in ASPP2-deficiency mice

BACKGROUND: Growing evidence indicates that lipid metabolism disorders and gut microbiota dysbiosis were related to the progression of non-alcoholic fatty liver disease (NAFLD). Apoptosis-stimulating p53 protein 2 (ASPP2) has been reported to protect against hepatocyte injury by regulating the lipid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Fang, Xu, Hang-fei, Zhang, Jing, Liu, Xiao-ni, Kou, Bu-xin, Cai, Meng-yin, Wu, Jing, Dong, Jin-ling, Meng, Qing-hua, Wang, Yi, Chen, Dexi, Zhang, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716097/ https://www.ncbi.nlm.nih.gov/pubmed/36466835 http://dx.doi.org/10.3389/fimmu.2022.974872

Ejemplares similares

Knockout of ASPP2 promotes DEN-induced hepatocarcinogenesis via the NF-κB pathway in mice
por: Wang, Shanshan, et al.
Publicado: (2021)

Dysregulated lipid metabolism links NAFLD to cardiovascular disease
por: Deprince, Audrey, et al.
Publicado: (2020)

ASPP2 inhibits hepatitis B virus replication by preventing nucleus translocation of HSF1 and attenuating the transactivation of ATG7
por: Wang, Shanshan, et al.
Publicado: (2021)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Gut Microbiota and Lifestyle Interventions in NAFLD
por: Houghton, David, et al.
Publicado: (2016)

TRIM31 Deficiency Is Associated with Impaired Glucose Metabolism and Disrupted Gut Microbiota in Mice
por: Cheng, Jing, et al.
Publicado: (2018)

Gut Microbiota: Association with NAFLD and Metabolic Disturbances
por: Lau, E., et al.
Publicado: (2015)

Gut Microbiota Metabolites in NAFLD Pathogenesis and Therapeutic Implications
por: Chen, Jiezhong, et al.
Publicado: (2020)

Nutritional Approach Targeting Gut Microbiota in NAFLD—To Date
por: Moszak, Małgorzata, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease
por: Xie, Fang, et al.
Publicado: (2015)

ASPP2 Plays a Dual Role in gp120-Induced Autophagy and Apoptosis of Neuroblastoma Cells
por: Liu, Zhiying, et al.
Publicado: (2017)

ASPP2 involvement in p53-mediated HIV-1 envelope glycoprotein gp120 neurotoxicity in mice cerebrocortical neurons
por: Liu, Zhiying, et al.
Publicado: (2016)

The Therapeutic Efficacy of Curcumin vs. Metformin in Modulating the Gut Microbiota in NAFLD Rats: A Comparative Study
por: Li, Ruifang, et al.
Publicado: (2021)

ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-β1 in Hepatic Stellate Cells by Reducing Autophagy
por: Lin, Minghua, et al.
Publicado: (2017)

CONSORT-Characteristics and metabolic phenotype of gut microbiota in NAFLD patients
por: Ge, Haize, et al.
Publicado: (2022)

Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax
por: Patel, Seema, et al.
Publicado: (2008)

ASPP1 deficiency promotes epithelial-mesenchymal transition, invasion and metastasis in colorectal cancer
por: Liu, Dian, et al.
Publicado: (2020)

ASPP2 Coordinates ERS-Mediated Autophagy and Apoptosis Through mTORC1 Pathway in Hepatocyte Injury Induced by TNF-α
por: Yao, Jia, et al.
Publicado: (2022)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

Lipid Disorders in NAFLD and Chronic Kidney Disease
por: Yang, Meng, et al.
Publicado: (2021)

Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD
por: Guo, Xin, et al.
Publicado: (2021)

The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD
por: Soderborg, Taylor K., et al.
Publicado: (2018)

The Positive Effects of Grifola frondosa Heteropolysaccharide on NAFLD and Regulation of the Gut Microbiota
por: Li, Xin, et al.
Publicado: (2019)

Chlorogenic Acid Improves NAFLD by Regulating gut Microbiota and GLP-1
por: Shi, Ameng, et al.
Publicado: (2021)

The identification of metabolites from gut microbiota in NAFLD via network pharmacology
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma
por: Liu, Kai, et al.
Publicado: (2015)

ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells
por: Wang, Y, et al.
Publicado: (2013)

iASPP regulates neurite development by interacting with Spectrin proteins
por: Wang, Junhao, et al.
Publicado: (2023)

ASPP2 expression predicts the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
por: Mao, Jiaren, et al.
Publicado: (2021)

Current Research on the Pathogenesis of NAFLD/NASH and the Gut–Liver Axis: Gut Microbiota, Dysbiosis, and Leaky-Gut Syndrome
por: Kobayashi, Takashi, et al.
Publicado: (2022)

Thioredoxin/Glutaredoxin Systems and Gut Microbiota in NAFLD: Interplay, Mechanism, and Therapeutical Potential
por: Zhu, Minghui, et al.
Publicado: (2023)

The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson’s disease
por: Li, Qing, et al.
Publicado: (2023)

Gut Microbiota-Derived Components and Metabolites in the Progression of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Ji, Yun, et al.
Publicado: (2019)

ASPP1/2 positive patients with invasive breast cancers have good prognosis
por: Wang, Changsong, et al.
Publicado: (2023)

Biotransformation of Liquiritigenin into Characteristic Metabolites by the Gut Microbiota
por: Keranmu, Adili, et al.
Publicado: (2022)

Glucokinase regulatory protein: a balancing act between glucose and lipid metabolism in NAFLD
por: Zhang, Ziqi, et al.
Publicado: (2023)

ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
por: Liang, Beibei, et al.
Publicado: (2019)

Changes in Lipidomics, Metabolomics, and the Gut Microbiota in CDAA-Induced NAFLD Mice after Polyene Phosphatidylcholine Treatment
por: Zhang, Jiayuan, et al.
Publicado: (2023)

Scramblases as Regulators of Autophagy and Lipid Homeostasis: Implications for NAFLD
por: Chen, Allen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gf4qlbe8ksfrk6cpajffon613s